Skip to main content
Sign In

University of Colorado College of Nursing

College of Nursing
 

Mary Weber, PhD, PMHNP-BC, FAANP

Associate Professor


Mary Weber

Mary.Weber@ucdenver.edu

Mary Weber, PhD, PMHNP-BC, FAANP is a psychiatric nurse practitioner, Specialty Coordinator of the Family Psychiatric Nurse Practitioner Program, and Endowed Professor in Psychiatric Nursing for the University of Colorado College of Nursing. She has extensive clinical and teaching expertise in chronic mental illness, psychiatric assessment, medication management, and individual/group therapies, having received National Teaching Awards and gained induction into the American Association of Nurse Practitioners. She has had grants funded by the Stanley Foundation, HRSA, and SAMHSA, and she has had numerous national presentations and publications. Her research has focused on underserved populations, including the homeless, those with co-morbid psychiatric and medical disorders, and those with post-partum depression. Her current SAMHSA work involves the integration of SBIRT into undergraduate and graduate curricula. She also practices currently in one of the addiction, research, and treatment programs sponsored by the Department of Psychiatry.

Degree Awarding Institution Field of Study Graduation Date
BSN University of Miami
Coral Gables, Florida
Nursing 1980
MSN/ARNP University of Miami
Coral Gables, Florida
Geriatric /Gerontological 1984
Post-MSN, PMHNP University of Florida
College of Nursing
Gainesville, Florida
Adult Psych NP/CNS 1991
PhD University of Florida
College of Nursing
Gainesville, Florida
Nursing 1997
  1. Weber, M., Thompson, L., Schmiege, S. Peifer, K., & Farrell, E. (2013). Perception of access to health care by homeless individuals seeking services at a day shelter. Archives of Psychiatric Nursing, 27, 179-184.
  2. Corwin, E. J., Guo, Y., Pajer, K., Lowe, N.,...Weber, M., Pace, T., & Stafford, B. (2013). Immune dysregulation and glucocorticoid resistance in minority and low-income pregnant women. Psychoneuroendocrinology, 38(9), 1786-1796. doi: 10.1016/j.psyneuen.2013.02.015. Epub 2013 Mar 26.
  3. Weber, M., Delaney, K., McCoy, K., Snow, D., Rhoads Scharf, M., & Brackley, M. (2012).  Quality and safety graduate competencies in psychiatric mental health nurses practitioner education. Archives of Psychiatric Nursing, 26, 350-357.
  4. Galbraith, M. E., Weber, M., & Thompson, L. (2012). Homelessness: US overview and Colorado exemplar from a psychiatric/mental health nursing perspective. Journal of Japanese Community Collaboration for Psychiatric Mental Health Nursing, 2, 10-21.
  5. Weber, M. (2010). The importance of exercise in the chronically mentally ill. Invited manuscript for a special issue on adjunctive treatments, Journal of Psychosocial Nursing and Mental Health Services (0279-3695), 48(10), 35-40.
  6. Weber, M., Gutierrez, A., Mohammadi, M. The risks and benefits of switching antipsychotics: A case study approach. Accepted for publication, Perspectives in Psychiatric Care.
  7. Weber, M., Colon, M., & Nelson, M. (2008). Pilot study of a cognitive behavioral group intervention to prevent further weight gain in Hispanic individuals with schizophrenia. Journal of the American Psychiatric Nurses Association, 13, 353-359.
  8. Weber, M. & Snow, D. (2006). An introductory clinical core course in Psychiatric Management: An innovative lifespan course blending all nurse practitioner majors, Perspectives in Psychiatric Care, 42, 245-251.
  9. Weber, M. & Wyne, K., (2006) A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83, 95-101.
  10. Henderson, David, Cagliero, Copeland, Borba, Evins, Hayden, Weber, M.T., et al. (2005).   Glucose metabolism in schizophrenia patients treated with atypical antipsychotics: A frequent sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis. Archives of General Psychiatry, 62, 19-28.
  11. Byerly, J., Lescouflair, E., Weber, M., Bugno, R, Fisher, R., Carmody, T...Rush, A. (2004). An open-label trial of Quetiapine for antipsychotic-induced sexual dysfunction. Journal of Sex and Marital Therapy, 30, 325-332.
  12. Byerly, M., Weber, M., Brooks, D., Casey, S., Elliot, S., & Hawkins, J (2003). Cost evaluation of Risperidone versus Olanzapine: A database and chart review. Psychiatric Services, 54, 742-744.
  13. Allison, D. & Weber, M. (2003). Treatment and prevention of obesity: What works, what doesn't work, and what might work. Lipids, 38, 147-155.
  14. Weber, M.T. (2002). Triggers for self-abuse: A qualitative study. Archives of Psychiatric Nursing, 16, 118-124.
  15. Byerly, M.J., Weber, M.T., Snow, L., Worley, M., & Slater, A. (2001). Cognitive effects of antipsychotics in the elderly. Drugs and Aging, 18, 45-61.
  16. Hudson, A., Jones, L., & Weber, M.T. (1999). Adult survivors of childhood sexual abuse as patients: Two case studies. Journal of Wound, Ostomy, and Continence Nursing, 26, 60-65.
  17. Tappen, R. & Weber, M. T. (1992). Treating clients and families together in an Alzheimer day care center. American Journal of Alzheimer's Care and Research, 7, 24-30.
  18. Brower, H., Tappen, R., & Weber, M. T. (1988). Missing links in nurse practitioner education. Nursing and Health Care, 9, 33-36.

2013 Inducted as Fellow in American Association of Nurse Practitioners

2012 Dean's Teaching Award, CU College of Nursing

2012 International Society of Psychiatric Mental Health Nurses Clinical Practice Award

2010 Accepted as Fellow in University of Colorado Excellence in Leadership Program

2008 Endowed Professor in Psychiatric Nursing, University of Colorado

2007 International Society of Psychiatric-Mental Health Nurses 2007 Education Award

  • Nurses Helping Colorado-Regional SBIRT Training Program ($743,177), SAMHSA (PI), 9/1/13-8/30/16
  • Planning Palliative Care for Homeless Veterans Who Are at the End of Life ($331,675), Federal Health Services Research and Development (Co-PI), 1/1/13-6/30/16
  • Psychoneuroimmune Contributions to Postpartum Depression ($1,799,346), NIH (Co-PI), 9/29/09-6/30/13
  • 2007/2008 Principal Investigator, Genomic predictors of Diabetes and obesity in high-risk populations with schizophrenia.
  • 2006/2007 Principal Investigator, Diabetes and Cardiovascular Risk Assessment in African American females with Schizophrenia.
  • 2005/2006 Co-Principal Investigator, University of Texas at Arlington, with David Henderson, MD, Harvard University, "An open label trial of ziprasidone as an adjunct to clozapine or olanzapine associated diabetes mellitus, impaired fasting glucose, or insulin resistance in chronic schizophrenia" $10,000 to DallasMetrocare for startup funds.
  • 2003 Principal Investigator, University of Texas at Arlington School of Nursing Faculty Scholarship, $5000.00 for salary support for summer, 2003 Pilot study on Cognitive/Behavioral group intervention for Hispanic subjects with schizophrenia.
  • 2003 Principal Investigator, University of Texas at Arlington Research Enhancement Grant, $10,000 for Research Assistant and patient costs, September 1, 2003- September 1, 2004 "The effects of a 12 week Cognitive/Behavioral intervention on hyperglycemia and weight gain among individuals with schizophrenia taking atypical antipsychotics"
  • 2002 Investigator, Pilot study on Cognitive/Behavioral Group for the treatment of antipsychotic-induced weight gain. No funding source.
  • 2001 Awarded NIMH/NINR Mentorship program: Building Capacity of Psychiatric Mental Health Researchers, $1500, mentor Dr. David Allison from University of Alabama at Birmingham, submitted "mock" RO1 for committee review and feedback (2003)